Skip to main content
. Author manuscript; available in PMC: 2024 Dec 16.
Published in final edited form as: Cancer Prev Res (Phila). 2014 Jan 17;7(4):378–387. doi: 10.1158/1940-6207.CAPR-13-0389

Table 4.

Correlates Associated with Discontinuing Endocrine Therapy or Non-Adherence

Reason Study
Side effects Demissie 2001, Kahn 2007, Lash 2006, Cluze 2012
Higher co-morbidity Hershman 2010, Hadji 2013, Sedjo 2011
Financial considerations or low SES Kimmeck 2001, Neugut 2011, Liu 2013, Riley 2011
Very young or older age Hershman 2010, Owusu 2008, Land 2011
Lack of physician recommendation Davidson 2007
Perception of low risk of recurrence Fink 2004
Lack of social support Cluze 2013, Land 2011
Follow-up care with general practitioner vs. oncologist Murphy 2012
African American race/ethnicity Hershman 2010
Cigarette smoking Land 2011
Presence of anxiety/depression linked to better adherence KyverNitankis 2013, Hadji 2013
Alcohol use Land 2011